Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank51
Year-over-Year Change
Year-over-year book value per share growth
Latest
-11.10%
↓ 149% vs avg
Percentile
P51
Within normal range
Streak
2 qtr
Consecutive growthRecovering
Average
22.58%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -11.10% |
| Q2 2025 | -13.14% |
| Q1 2025 | -14.71% |
| Q4 2024 | -14.65% |
| Q3 2024 | -5.55% |
| Q2 2024 | -14.20% |
| Q1 2024 | -11.62% |
| Q4 2023 | -10.33% |
| Q3 2023 | -8.77% |
| Q2 2023 | -8.12% |
| Q1 2023 | -5.77% |
| Q4 2022 | -21.17% |
| Q3 2022 | -4.39% |
| Q2 2022 | -10.23% |
| Q1 2022 | -26.10% |
| Q4 2021 | -9.30% |
| Q3 2021 | 69.78% |
| Q2 2021 | -6.61% |
| Q1 2021 | -22.45% |
| Q4 2020 | 28.49% |
| Q3 2020 | -48.57% |
| Q2 2020 | -6.03% |
| Q1 2020 | -31.41% |
| Q4 2019 | -19.84% |
| Q3 2019 | -59.87% |
| Q2 2019 | -17.47% |
| Q1 2019 | 10.86% |
| Q4 2018 | -10.65% |
| Q3 2018 | -17.84% |
| Q2 2018 | -1.12% |
| Q1 2018 | -10.17% |
| Q4 2017 | 50.12% |
| Q3 2017 | -17.08% |
| Q2 2017 | -19.01% |
| Q1 2017 | 759.89% |
| Q4 2016 | -71.35% |
| Q3 2016 | -19.37% |
| Q2 2016 | -25.46% |
| Q1 2016 | 665.77% |
| Q4 2015 | -88.26% |